NCT02270281View on ClinicalTrials.gov

Dexmedetomidine on Microcirculation in Septic Shock

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

May 31, 2017

Conditions
Septic Shock
Interventions
DRUG

Dexmedetomidine 0.7 Mcg/kg/h

CIF 0.7mcg/kg/h

Trial Locations (1)

210000

Zhongda Hospital Southeast University, Nanjing

All Listed Sponsors
lead

Southeast University, China

OTHER

NCT02270281 - Dexmedetomidine on Microcirculation in Septic Shock | Biotech Hunter | Biotech Hunter